HMGCR and breast carcinoma: Other studies found that β-ionone suppression of the growth of Murine B16 melanoma, breast cancer, human leukemia, human colon adenocarcinoma [3] and prostate tumor cell lines was conveyed via reducing HMG CoA reductase activity [74].